HBM Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 6
Professionals
  • Investments
  • 146
  • Portfolio
  • 39
  • Exits
  • 88
Exits

HBM Partners General Information

Description

Founded in 2001, HBM Partners is a venture capital firm based in Zug, Switzerland. The firm prefers to invest in early-stage, growth stage, buyout, and in public companies. The firm seeks to make investments in the entrepreneurial biopharma and healthcare sectors.

Contact Information

Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Asset Manager
Growth/Expansion
PE/Buyout
Primary Office
  • Bundesplatz 1
  • 6301 Zug
  • Switzerland
+41 043 000 00 00

HBM Partners Investments (146)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Genalyte 11-Jan-2021 Later Stage VC 0000 Diagnostic Equipment Generating Revenue
00000 000000 08-Jan-2021 00000 00000 00000 Pharmaceuticals Generating Revenue
0000 000000 31-Dec-2020 00000 00000 00000 Drug Discovery Startup
00000000 15-Dec-2020 00000 00000 0000 Drug Discovery Startup
000000000 00000000 28-Oct-2020 00000 00000 0000 Drug Discovery Startup 0000000 000 00
00000000 15-Oct-2020 00000 00000 000.00 Pharmaceuticals Generating Revenue 00000000 0000000 00.0
0000000 25-Sep-2020 00000 00000 0000 Drug Discovery Startup
0000000000 21-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1
Monte Rosa Therapeutics 15-Sep-2020 Early Stage VC 0000 Drug Discovery Generating Revenue 0000000 000 00
Dren Bio 11-Sep-2020 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials
You’re viewing 10 of 146 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

HBM Partners Exits (87)

Company Name Exit Date Exit Type Exit Size
Galecto 29-Oct-2020 IPO 0000
0000000 000000000 09-Oct-2020 000 00000
00 000000000000 02-Oct-2020 000 00000
0000000 21-Sep-2020 000000000000000000
0000000 01-Sep-2020 000000000000000000 0000
0000000 0000000000 19-Aug-2020 000 00000
000000 0000000000 12-Aug-2020 000 00000
00000 000000000000 24-Jul-2020 000 00000
ALX Oncology 17-Jul-2020 IPO 00000
Corvidia Therapeutics 11-Jun-2020 Merger/Acquisition 00.00
You’re viewing 10 of 87 exits. Get the full list »

HBM Partners Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore HBM Partners‘s full profile, request access.

Request a free trial

HBM Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

HBM Partners Team (31)

Name Title Deals Funds Boards Office
Ulrich Geilinger Ph.D Investment Advisor Private Equity 00 0 0 Zug, Switzerland
Erwin Troxler Chief Financial Officer Zug, Switzerland
Cindy Chen Chief Operating Officer & Executive, Business Development, Risk and Compliance Zug, Switzerland
Steve Chen Managing Director and Investment Advisor Zug, Switzerland
Michael Buschle Ph.D Venture Partner Private Equity Zug, Switzerland
You’re viewing 5 of 31 team members. Get the full list »

HBM Partners Co-Investors (233)

Name With Exits Lead Partner Series Industry
HBM Healthcare Investments 48 0 0 Series chart Industry bar
Cormorant Asset Management 0 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
RA Capital Management 0 0 Series chart Industry bar
Bain Capital 0 0 Series chart Industry bar
You’re viewing 5 of 233 co-investors. Get the full list »